| Application no. and date | 20187001.1 (espacenet) (Federated) (European Patent Register), 20111104 | | Patent/reg. no. and date | DK/EP 3757126, 20250903 | | Publication date | 20201230 | | Priority no. and date | US 41053310 P, 20101105 | | EP pub. no. and date |
EP 3757126 20201230 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V495628DK00 | | Inventor | MPOFU, Shepard, Novartis Pharma AG
Postfach
4002 Basel, CH,
RICHARDS, Hanno, Novartis Pharma AG
Postfach
4002 Basel, CH,
THANGAVELU, Karthinathan, Novartis Pharma AG
Postfach
4002 Basel, CH,
MACHACEK, Matthias, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 39/395 (2006.01) , C07K 16/24 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF PSORIASISGIGT VED HJÆLP AF IL-17-ANTAGONISTER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
